Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat

समान संसाधन

• Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Ex Vivo Lipopolysaccharide-Induced Inflammatory Responses
  द्वारा: Brinkmann, Christel Rothe, और अन्य
  प्रकाशित: (2018)
• Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System
  द्वारा: Rasmussen, Thomas A., और अन्य
  प्रकाशित: (2015)
• Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
  द्वारा: Gunst, Jesper D, और अन्य
  प्रकाशित: (2019)
• Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
  द्वारा: Bjerg Christensen, Ane, और अन्य
  प्रकाशित: (2015)
• Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
  द्वारा: Ane Bjerg Christensen, और अन्य
  प्रकाशित: (2015-01-01)